Unliganded steroid receptors are assembled into heterocomplexes with heatshock protein (hsp) 90 by a multiprotein chaperone machinery. In addition to binding the receptors at the chaperone site, hsp90 binds cofactors at other sites that are part of the assembly machinery, as well as immunophilins that connect the assembled receptor-hsp90 heterocomplexes to a protein trafficking pathway. The hsp90-/hsp70-based chaperone machinery interacts with the unliganded glucocorticoid receptor to open the steroid-binding cleft to access by a steroid, and the machinery interacts in very dynamic fashion with the liganded, transformed receptor to facilitate its translocation along microtubular highways to the nucleus. In the nucleus, the chaperone machinery interacts with the receptor in transcriptional regulatory complexes after hormone dissociation to release the receptor and terminate transcriptional activation. By forming heterocomplexes with hsp90, the chaperone machinery stabilizes the receptor to degradation by the ubiquitin-proteasome pathway of proteolysis.
manufacture being increased in stressed cells, it performs a variety of housekeeping functions in unstressed cells. For the steroid receptors, hsp90 functions as a cradle-to-grave chaperone, in that it regulates proper receptor folding, trafficking, transcriptional activation and turnover [1] . Some 20 years ago, hsp90 was shown to be associated with the oncogenic protein tyrosine kinase v-Src, and it is now known to bind to and regulate the function of approx. 100 transcription factors and protein kinases involved in signal transduction, a process of identification that was greatly aided by the hsp90 inhibitor geldanamycin [2] . Of these many 'client' proteins for hsp90, the assembly of steroid receptor-hsp90 complexes is the best defined, and most studies of hsp90's effects on receptor function in vivo have focused on the glucocorticoid receptor (GR). In this chapter, we will use the GR to illustrate the effects of hsp90 and other molecular chaperones (e.g. hsp70) on steroid receptors. The same mechanism that we describe here for assembly of GR-hsp90 heterocomplexes applies to the assembly of hsp90 complexes with other transcription factors and with protein kinases involved in a variety of signalling pathways [2] .
Hsp90 acts on the ligand-binding domain (LBD) of steroid receptors
Although hsp90 and hsp70 may function individually as chaperones that bind to exposed hydrophobic amino acids in denatured or partially denatured proteins and through rounds of binding and release facilitate protein renaturation, this is not the way that they function on steroid receptors. The binding of hsp90 to the receptors is the result of the co-ordinated action of several proteins that function together as an hsp90-/hsp70-based chaperone machinery for the ATP-dependent assembly of receptor-hsp90 heterocomplexes. These complexes are formed specifically with the LBD in the C-terminal one-third of the receptor (Figure 1 ). For the GR and some of the other steroid receptors, hsp90 must be bound to the LBD for it to have highaffinity steroid-binding activity. Removal of hsp90 from the GR (with salt, for example) is accompanied by immediate loss of steroid-binding activity, and the LBD can be returned to the steroid-binding state by the chaperone machinery. There is no evidence that the hsp90-free GR is in any way denatured; rather, the hydrophobic steroid-binding cleft appears to be collapsed such that the LBD is in a native, minimal-energy conformation. Energy in the form of ATP is then required for the hsp90-/hsp70-based chaperone machinery to open up the cleft during GR-hsp90 heterocomplex assembly, regenerating steroid-binding activity. Thus when hsp90 and hsp70 operate together as part of the chaperone machinery, they open a hydrophobic cleft in a properly folded state of the GR, rather than promoting the refolding of a partially denatured GR, as occurs classically in chaperone-mediated events. Once the cleft is open, it remains open as long as the LBD is maintained in a metastable complex with hsp90.
Subsequent binding of steroid deep within the cleft facilitates a temperature-dependent collapse, or closing, of the cleft with loss of the GR's ability to form 'persistent' complexes with hsp90. This liganded form of the GR is said to be 'transformed' or 'activated' because it can now move to the nucleus and be transcriptionally active [1] . Although the transformed, liganded GR can interact in very dynamic fashion with the chaperone machinery, the persistent heterocomplexes with hsp90 that are typical of client protein-hsp90 complexes in general can only be formed again after the steroid has been released from its hydrophobic nest in the interior of the LBD. This ability of the steroid to regulate the interaction of the receptor with the chaperone machinery is the key initial event in signal transduction by steroids.
Hsp90 acts at the opening of the steroid-binding cleft
The study of the interaction of the chaperone machinery with the GR may have given us some insight as to how hsp90 can form complexes with so many signalling proteins regardless of their amino acid sequence and without a requirement that the protein be in a non-native state. There is a very focal site of attack for the chaperone machinery on the surface of the GR that lies at the N-terminus of the LBD. Hsp90 binding requires the presence of a short segment of the LBD that has no defined amino acid composition (Figure 1 ), and this segment lies at the rim of the steroid-binding cleft [3] . Virtually all soluble proteins in native conformation have regions where the hydrophobic surfaces of the protein interior merge with their hydrophilic exterior. Such hydrophobic cleft openings may be the general topological feature recognized by hsp70, which is the first component of the chaperone machinery to interact with the receptor [4] . We will return to this cleft-opening model below when we consider the choice between receptor stabilization by hsp90 versus receptor degradation via the ubiquitin-proteasome pathway.
The importance of the short segment at the rim of the ligand-binding cleft for both hsp90 binding and regulation of receptor function in vivo is highlighted by observations with a GR-retinoic acid receptor (RAR) chimaera [5] . Although the RAR requires the chaperone machinery to achieve its original Figure 1 . Domain structure of the GR The borders of four domains of the rat GR are defined: the activation domain (AD), involved in co-factor interaction; the DNA-binding domain (DBD); the hinge domain, which contains a nuclear localization signal and a binding site for FKBP52; and the LBD. The short segment in blue at the extreme N-terminus of the LBD lies at the lip of the steroid-binding cleft and is required for hsp90 binding to the GR. steroid-binding state, it does not form persistent complexes with hsp90, and it does not remain in the cytoplasm of hormone-free cells, as does the GR. When a fragment of the GR from the N-terminus through the dark blue segment shown in Figure 1 was fused to the complementary RAR LBD fragment extending to its C-terminus, the chimaera was complexed with hsp90 and underwent cytoplasmic-nuclear translocation in response to retinoic acid.
The LBD is a transferable regulatory unit
It has been known for many years that fusion of a steroid receptor LBD to other transcription factors, such as the viral E1A protein, may yield a chimaera in which transcriptional activity is regulated by steroid binding [6] . This ability of the LBD to function as a moveable 'regulatory cassette' is now known to be due to the transfer of steroid-regulated hsp90 binding on to an otherwise constitutively acting protein. The cleft hypothesis gives us a general basis for understanding how such a regulatory system may have evolved. It is likely that the interaction of the chaperone machinery with the regions where clefts merge with the surfaces of most native proteins is a highly dynamic process. We will see later how such dynamic interactions are useful for attaching the liganded receptor to a system for rapid protein movement. The evolution of more persistent hsp90 attachment to the now partially opened cleft allowed the steroid to enter the hydrophobic cleft and regulate the hsp90 interaction with the receptor. In other cases, hsp90-dependent opening of hydrophobic clefts may facilitate the entry of hydrophobic cofactors, such as haem or flavin, into the interior of an enzyme. This is the case with the more dynamic interaction of hsp90 with neuronal nitric oxide synthase, where the chaperone machinery acts on the apo-enzyme to promote haem entry, which in turn permits homodimerization and activation of catalytic activity [7] . In many signal transduction systems, a persistent interaction of hsp90 with a protein, or proteins, in the signalling pathway stabilizes the protein to rapid degradation by the ubiquitin-proteasome pathway. Thus the chaperone machinery serves to maintain the abundance of a key protein, usually a protein kinase, such that normal signal transduction occurs. In this case, cleft opening may not be critical for permitting entry of a ligand, but we will discuss below how interaction of the machinery with the cleft opening is likely to be critical for determining whether an hsp90-regulated protein will be stabilized or degraded.
Assembly of receptor-hsp90 heterocomplexes
Although receptor-hsp90 heterocomplexes could readily be isolated from cell cytosols by immunoprecipitation of unliganded receptors, initial attempts to form them under cell-free conditions failed. Purified hsp90 does not bind to purified receptor, and it was not until receptors were translated in reticulocyte lysate that cell-free assembly was achieved. A system was then set up in which an unliganded receptor was immunoadsorbed, and the receptor was stripped of its bound hsp90 by washing the immune pellets with a salt solution. In the case of the GR, we now have an aporeceptor without steroid-binding activity. When this immunopurified aporeceptor is incubated with rabbit reticulocyte lysate, the GR is assembled into a heterocomplex with hsp90, with simultaneous regeneration of steroid-binding activity. Once this cell-free assembly system was available, the major components of the assembly system were identified. Receptor-hsp90 assembly is now carried out with a combination of five purified proteins -hsp90, hsp70, Hop (hsp organizer protein), hsp40, p23 -that comprises a minimal system for efficient assembly of signalling protein-hsp90 heterocomplexes in general [2] .
The master chaperones: hsp90 and hsp70
Hsp90 and hsp70 are both chaperones possessing nucleotide-binding sites that regulate their conformations. In each case, the ATP-bound conformation has a low affinity for binding hydrophobic peptide, and ATP hydrolysis resulting from the intrinsic ATPase activity of the chaperone is accompanied by a conformational change to a state with high affinity for binding hydrophobic peptide [8, 9] . The ATPase activity of both proteins is essential for their biological function and is regulated by co-chaperones. Hsp70 is essential for assembly of receptor-hsp90 heterocomplexes. Although the two proteins alone do not assemble GR-hsp90 heterocomplexes that are persistent, they are sufficient for transient opening of the steroid-binding cleft [10] . The hydrolysis of ATP by hsp70 is potassium-dependent, and GR-hsp90 heterocomplex assembly is K + -dependent, as well as MgATP-dependent. Hsp90 contains a dimerization domain at its C-terminus, it functions as a dimer, and there is one molecule of receptor bound to two molecules of hsp90 in the final heterocomplex. Hsp90 is a member of a small family of proteins, the GHKL (gyrase, hsp90, histidine kinase, MutL) family, which possess a unique binding pocket for ATP. The hsp90 inhibitors geldanamycin and radicicol bind to this N-terminal nucleotide-binding site and prevent hsp90 from assuming its ATPdependent conformation, thus blocking receptor-hsp90 heterocomplex assembly and opening of the steroid-binding cleft.
The hsp90-/hsp70-based chaperone machinery When hsp70 and hsp90 act on the GR in reticulocyte lysate they act in concert with several other proteins as a machinery in which Hop brings the two master chaperones together, as shown in Figure 2 . Hop contains two tetratricopeptide repeat (TPR) domains that bind independently to hsp90 and hsp70. TPR domains are 34-amino-acid repeats that function as protein-binding regions, and hsp90 has a TPR acceptor site at its C-terminus. Although Hop is not essential for GR-hsp90 heterocomplex assembly, when Hop is present to bring hsp90 and hsp70 together, forming a machinery, the rate of assembly is much faster [10] . Hop does not act solely as a tie rod to bring the master chaperones together; it also influences the conformational state and function of each protein [11] . As indicated in Figure 2 , the machinery also contains hsp40, a co-chaperone that binds to hsp70 and promotes its ATPase activity. The machinery forms spontaneously on mixing of the purified proteins, and the immunoadsorbed hsp90-Hop-hsp70-hsp40 complex has everything necessary to convert the LBD into the steroid-binding state when it is incubated with the immunoadsorbed GR. Although all of the Hop and about one-third of the hsp90 in reticulocyte lysate are present in the hsp90-Hop-Hsp70-hsp40 complex [12] , it is not known if the preformed machinery interacts with the closed cleft form of the GR, as shown in the simplified assembly model in Figure 2 . There may be a
Figure 2. Model of GR-hsp90 heterocomplex assembly
The hsp90-/hsp70-based chaperone machinery converts the GR LBD from a folded conformation in which the steroid-binding cleft is closed and not accessible to hormone into an open-cleft conformation that can be accessed by steroid. Hop binds via independent TPR (tetratricopeptide repeat) domains to hsp90 and hsp70 to form the chaperone machinery. The hsp90-Hop-hsp70-hsp40 machinery contains all the components necessary to carry out the MgATP-and K + -dependent opening of the steroid-binding cleft. When the cleft is open, hsp90 is in its ATP-dependent conformation, which is dynamically stabilized by p23, and Hop is released from hsp90. Thus the complex shown at the end of step 2 represents a composite in which several changes are occurring in dynamic fashion. After the exit of Hop, an immunophilin (IMM) can bind to the single TPR acceptor site on the receptor-bound hsp90 dimer. The hsp90-binding TPR domains of Hop and immunophilins are indicated by the solid black crescents. Much of the hsp70 leaves the intermediate complex during assembly, and the broken line for hsp70 in the final heterocomplex indicates that it is present at substoichiometric levels with respect to the receptor. requirement that the machinery be assembled on the receptor as the individual components bind in a specific sequence to open the steroid-binding cleft during receptor-hsp90 heterocomplex assembly [13, 14] .
Assembly is a dynamic process
To achieve an open steroid-binding cleft, the receptor-bound hsp90 must assume a conformation induced by ATP. This is the conformation of hsp90 that recognizes p23, which now binds the receptor-bound hsp90 and stabilizes the GR-hsp90 heterocomplex [15] . p23 is the only member of the five-protein assembly system that does not exist in the machinery (i.e. the hsp90-Hop-hsp70-hsp40 complex), but it is shown in Figure 2 to bind to the GR-bound hsp90 when the other members are present as part of a receptorbound machinery. This is a diagrammatic oversimplification of what is really a dynamic series of events. As the steroid-binding cleft is being opened, hsp90 achieves its ATP-bound state, Hop dissociates from the receptor-bound hsp90, and p23 binds. Also, a considerable amount of hsp70 dissociates from the GR during the cleft-opening process, leaving a steroid-binding state of the GR that is bound to hsp90, p23 and a variable, but substoichiometric, amount of hsp70 (indicated by the shape with the dashed outline in Figure 2 ). Although a general sequence of events can be described, the factors that control the exit of Hop and hsp70 are not known.
The product of assembly with the purified five-protein system is a GR-hsp90-p23 complex in which the TPR acceptor site on hsp90 is empty. In reticulocyte lysate or in intact cells where a variety of TPR domain immunophilins are available, the immunophilins compete with each other to occupy the TPR acceptor site. Thus as we will describe, a variety of final heterocomplexes may exist, depending upon the immunophilin that is occupying the TPR acceptor site on hsp90 at any time.
Mechanism of cleft opening
Although the cleft-opening process is indicated as a single step (step 2) in Figure 2 , stepwise assembly experiments have begun to separate the process into an ordered series of events shown in Figure 3 . Two independent, ATPrequiring steps have been resolved [13] .
Priming of the receptor by hsp70
The first step in assembly is the 'priming' of the GR to form a GR-hsp70 complex that then binds Hop and hsp90. In this first step, the immunoadsorbed GR is incubated with hsp70 and hsp40 in the presence of MgATP and K + . This produces a 'primed' GR-hsp70-hsp40 complex that can be washed free of unbound hsp70 and hsp40, and then incubated with purified Hop, hsp90 and p23 to produce a GR-hsp90 complex with an open steroidbinding cleft that can be accessed by hormone. Hsp40 is not essential for GR priming, but its presence doubles or triples the amount of primed GR-hsp70 complex that is produced. Thus both ATP binding and ATP hydrolysis are required for priming.
The attack on the GR is not only focal at the cleft opening but also limited in the sense that only one or at most two molecules of hsp70 are bound to the GR in the primed complex. The receptor in the primed GR-hsp70 complex cannot bind steroid, but something has happened to the steroid-binding cleft, probably a partial opening of the cleft, such that it can accept hsp90. Hsp70 in its ATP-dependent conformation binds to the naked GR, and if hsp70 is converted first into its ADP-dependent conformation, there is no binding to the GR [4] . After the priming step, the GR-bound hsp70 is in both ADP-bound and ATP-bound states, and there is evidence that once hsp70 has bound to the GR, the chaperone may oscillate back and forth between ATP-bound and ADP-bound configurations during the priming step [16] . The ATP-dependent conformation of hsp70 binds initially to the naked GR, and in an ATP-, K + -and hsp40-dependent step, a 'primed' GR-hsp70 complex is formed that can bind hsp90. After hsp90 binding, there is a second ATP-and K + -dependent step (or steps) that is rate-limiting and leads to opening of the steroid-binding cleft to access by a steroid. The GR-bound hsp90 is now in its ATP-dependent conformation and can be bound by p23, which stabilizes the chaperone in that conformation, preventing disassembly of the GR-hsp90 heterocomplex. The hsp40 and Hop components of the five-protein assembly system have been omitted from later steps for simplicity. 
Other co-chaperones
The five-protein system is a minimal system for efficient receptor-hsp90 heterocomplex assembly, and there are additional co-chaperones in this process in cells. For example, a family of hsp90 co-chaperones called Aha (activator of hsp90 ATPase) has recently been identified [17] . The Aha proteins are themselves stress proteins, and they bind to hsp90 and stimulate its inherent ATPase activity, much like DnaJ proteins, such as hsp40, stimulate the ATPase activity of hsp70. Aha1 has been shown to be necessary for hsp90-dependent activation of the protein tyrosine kinase v-Src in vivo, and it seems that it must play some role in steroid-receptor regulation by hsp90 in vivo, although it may do so only under stress conditions. BAG-1 (Bcl-2-associated gene product-1), also called RAP46 (46 kDa receptor-associated protein), is a co-chaperone that binds to the ATPase domain of hsp70 and accelerates the release of ADP. BAG-1 is recovered in steroid receptor heterocomplexes, and overexpression of BAG-1 inhibits GR binding to DNA and GR-dependent transactivation. Inhibition of GRdependent transcription by BAG-1 requires both its binding to hsp70, and BAG-1's ability to bind directly in a non-sequence-specific manner to DNA [18, 19] . The hsp90-/hsp70-based chaperone machinery is active in the nucleus as well as the cytoplasm, and BAG-1 is likely to play an important role in terminating transcriptional activation as GR-hsp90 heterocomplexes are formed when hormone levels decline. Another hsp70 co-chaperone found in steroid receptor heterocomplexes is Hip (hsp70-interacting protein). Hip also binds to the ATPase domain of hsp70, where it competes for the binding of BAG-1. It does not affect GR-hsp90 assembly by the five-protein machinery, but Hip and BAG-1 may play opposing regulatory roles on dynamic receptor-hsp90 assembly/disassembly in cells.
Hsp90 and GR function in vivo
Of the several effects of the chaperone machinery on GR function in vivo, the requirement of hsp90 for steroid-binding activity is the only one that has been studied in the purified system. Other effects of the machinery on receptor trafficking, nuclear receptor cycling and receptor turnover have been studied indirectly by using hsp90 inhibitors, such as geldanamycin and radicicol, or by overexpressing proteins or protein fragments that affect hsp90 function.
Receptor trafficking
The steroid receptors constantly pass into and out of the nuclei of hormonefree cells, and depending upon the receptor and the type of cell, the unliganded receptor at steady state may be predominantly cytoplasmic or nuclear [20] . In most cells, the unliganded GR is in the cytoplasm, and when it becomes bound by steroid it shifts to the nucleus. Normally, this steroid-dependent translocation is rapid (t 1/2 approx. 4.5 min), but treatment of cells with the hsp90 inhibitor geldanamycin lowers the rate of translocation by an order of magnitude. The rapid, hsp90-dependent movement occurs along cytoskeletal tracts, and the slow, hsp90-independent movement probably reflects diffusion [21] . In neurites, where random diffusion alone does not permit delivery of proteins over long distances, treatment with geldanamycin blocks GR movement. Thus a facilitory action of hsp90 in retrograde protein trafficking in the cell body becomes essential for trafficking in the specialized extensions of the cytoplasm that comprise the axons and dendrites. The binding of steroid deep within the binding pocket triggers the transformation of the receptor LBD to a state where it interacts very dynamically with the chaperone machinery, bringing the receptor into continuous association with and dissociation from hsp90 and the immunophilins, which, in turn, link the receptor complex to the motor protein responsible for retrograde movement to the nucleus.
Cytoplasmic dynein is known to be the motor protein responsible for retrograde movement of vesicles and organelles along microtubular tracks toward the nucleus [22] , and the connection between the GR and the motor via the hsp90-bound immunophilins is illustrated in Figure 4 . As we have shown in Figure 2 , the final GR-hsp90 heterocomplex is formed when a TPR domain immunophilin binds to the TPR acceptor site in the C-terminus of hsp90. The immunophilins are ubiquitous and conserved proteins that bind immunosuppressant drugs, such as FK506, rapamycin and cyclosporin A. All members of the immunophilin family have peptidylprolyl isomerase (PPIase) activity, and they may be divided into two classes: the FK506-binding proteins (FKBPs) are binding proteins for immunosuppressant compounds such as FK506 and rapamycin, and the cyclophilins (CyPs) bind cyclosporin A. The immunosuppressant drugs occupy the PPIase sites on the immunophilins and inhibit cis-trans isomerization of petidylprolyl bonds in vitro. For the steroid receptors, however, PPIase activity does not appear to be important; rather, the PPIase domains act as protein-protein interaction domains to link the receptors to cytoplasmic dynein [23] .
Four high-molecular-mass immunophilins with TPR domains have been discovered as components of steroid receptor-hsp90 complexes: FKBP52, FKBP51, CyP40 and PP5, the latter of which contains a protein phosphatase domain in addition to TPR and PPIase homology domains. When GR-hsp90 heterocomplexes are immunoadsorbed from cytosol with a monoclonal antibody against the GR, complexes with each of these TPR domain proteins are seen. These large receptor heterocomplexes also contain cytoplasmic dynein, and immunoadsorption of FKBP52, CyP40 or PP5 from cytosol yields coimmunoadsorption of dynein. The large GR-hsp90-immunophilin-dynein complexes shown in Figure 4 can be formed by incubating immunopurified aporeceptor with reticulocyte lysate, and the presence of dynein in the complexes is selectively eliminated by competition with a purified PPIase domain fragment, showing that it is the PPIase domain that links the complex to the motor [24] . Overexpression of the PPIase domain fragment in cells eliminates the rapid movement of the GR along microtubular tracts [24] by disconnecting the immunophilin component of the receptor heterocomplex from the motor protein [23] . Thus the chaperone machinery interacts dynamically with the liganded GR to form GR-hsp90 heterocomplexes containing one of several TPR domain immunophilins that, in turn, link the receptor to the dynein motor responsible for retrograde movement to the nucleus. Because of the dynamic nature of complex assembly and disassembly, the receptors should be repeatedly associated with and released from the motor protein, yielding a saltatory pattern of movement, like that seen for vesicles along microtubular tracts.
Receptor cycling within the nucleus
Although hsp90 is located predominantly in the cytoplasm, it is clear that both hsp90 and hsp70 move into and out of the nucleus [1] , and that the chaperone machinery functions within the nucleus [25] . It has been known for many years that the GR does not have DNA-binding activity when it is in heterocomplex with hsp90 and that the chaperone machinery in reticulocyte lysate acts on DNA-bound, hormone-free GR to convert the receptor into the non-DNA-binding state and restore steroid-binding activity [26] . This led to the proposal that hsp90 heterocomplex assembly is involved in the termination of transcriptional action when steroid dissociates from DNA-bound receptors in intact cells [26] .
After the liganded GR has translocated to its sites of action in the nucleus and associated with the appropriate co-activators and response elements to activate transcription, the receptor cycles out of the transcription complexes as the hormone dissociates. It has been shown in permeabilized cells depleted of the cytoplasmic chaperone machinery that nuclear GR can recycle to the hormone-binding state, rebind hormone and target to chromatin-binding sites without ever exiting from the nucleus [27] . During hormone withdrawal, both release of the GR from chromatin and generation of high-affinity steroidbinding activity in the nucleus are inhibited by geldanamycin [27] . This provides quite clear evidence that the chaperone machinery is active within the nucleus and that it may facilitate the termination of transcriptional activation as steroid dissociates from the receptor.
Consistent with this notion, p23 has been shown to disrupt GR-mediated transcriptional activation both in vitro and in vivo [28] . In this case, it was not established that p23 was acting through its ability to bind to and stabilize the ATP-dependent conformation of GR-bound hsp90 as shown in Figures 2 and  3 . However, it is a reasonable proposal that p23-promoted disruption of transcriptional regulatory complexes is mediated by the actions of the hsp90-/ hsp70-based chaperone machinery on the hormone-free GR. It has been known for some time that hormone withdrawal is accompanied by simultaneous termination of transcriptional activation. Thus it has been thought that as the level of glucocorticoid decreases, the hormone is released from the receptor. However, as we have seen, the situation is far more complex because glucocorticoid binding to the GR at physiological temperature does not reflect an equilibrium binding state. When steroid dissociates, the GR must undergo assembly into a complex with hsp90 before it can bind steroid again and new transcriptional regulatory complexes can form. This chaperone-machinerydependent assembly/disassembly cycle is probably occurring continually with transcriptional regulatory complexes in the nucleus, and when hormone levels decline, there is no free steroid to bind to newly assembled GR-hsp90 heterocomplexes and continue the cycle. Thus, the assembly/disassembly cycle allows for fine-tuned regulation of transcription according to changes in hormone level.
Receptor turnover
Treatment of cells with an hsp90 inhibitor, such as geldanamycin or radicicol, increases the degradation rate of many (probably all) client proteins that form persistent heterocomplexes with hsp90 [2, 29] . When hsp90 function is inhibited, the GR and the other client proteins are degraded by the ubiquitin-proteasome pathway of proteolysis [30] as shown in Figure 5 . The protein to be degraded becomes bound by a member of a family of ubiquitin ligases (E3), which brings the target protein and ubiquitin-charged E2 together into a complex for ubiquitin conjugation. Repetition of the process results in the formation of a polyubiquitin chain, and the polyubiquitylated protein is then recognized and degraded to small peptides by the 26 S proteasome complex, with the ubiquitin being recycled [30] . The GR and other steroid receptors are stabilized to ubiquitin-proteasomal degradation by being in complex with hsp90.
One E3 ligase for the GR is a 35 kDa cytoplasmic protein called CHIP (C-terminus of Hip) [31] . CHIP binds via a TPR domain to the C-terminus of both hsp70 and hsp90, and it possesses a C-terminal U-box that interacts with the ubiquitin-conjugating enzyme E2. CHIP and Hop bind to the same TPR acceptor sites on hsp70 and hsp90, and it has been suggested that competition between CHIP and Hop may modulate quality-control decisions between ubiquitin-dependent degradation and proper folding by the chaperone machinery [32] . However, it may be more productive to consider the triage decision from the viewpoint of the cleft-opening model.
As mentioned previously, the region where hydrophobic clefts emerge to the protein surface may be the general topological feature that is recognized by hsp70. If the cleft is such that it can be primed by hsp70, as is the unliganded GR in Figure 3 , then the primed GR-hsp70 complex may preferentially bind Hop and hsp90 and proceed to GR-hsp90 heterocomplex assembly ( Figure 6A ). However, if the cumulative effect of oxidative and other damage to the receptor is sufficient, cleft opening will occur spontaneously as hydrophobic amino acids are exposed during the early stages of denaturation. Instead of encountering a closed cleft that can be primed for hsp90 assembly, hsp70 encounters a cleft opening with significant hydrophobic character where a primed complex cannot be achieved, and the hsp70 bound to the emerging hydrophobic cleft interior may prefer to bind CHIP and proceed towards degradation ( Figure 6B ). Thus hsp70 would make the triage decision in binding to the native (closed cleft) versus nascently denaturing (opening cleft) forms of the protein. We know that hsp70 conformation makes a difference, because in the absence of substrate, the ADPbound conformation binds with higher affinity to Hop than the ATP-bound conformation [11] . How this preference is affected by the binding of substrate protein is unknown, but it shows that the nucleotide-binding conformation of hsp70 affects the binding properties of its TPR acceptor site. It is clear that pathways A and B in Figure 6 are not exclusive. After Hop leaves the TPR-binding site on GR-bound hsp70, the hsp70 can bind CHIP. Thus CHIP has been recovered with GR-hsp90 heterocomplexes, and it has been shown that both CHIP and hsp70 undergo retrograde movement with the GR that is hsp90-dependent. Although CHIP can be in the complex when hsp90 is bound to the GR, it apparently cannot bind ubiquitin-charged E2 and proceed with ubiquitylation. However, inhibition of hsp90 binding with geldanamycin or radicicol permits ubiquitylation and an increased rate of GR turnover.
Although CHIP can bind the TPR acceptor site in hsp90, it does not seem reasonable that its binding to GR-bound hsp90 signals receptor degradation. In all of the cases examined so far, formation of heterocomplexes with hsp90 stabilizes client proteins and inhibition of heterocomplex assembly by geldanamycin and radicicol promote degradation by the ubiquitin-proteasome pathway [2, 29] . By extending the cleft-opening model of chaperone machinery Figure 6 . The triage decision between GR-hsp90 heterocomplex assembly and GR ubiquitylation and degradation Hsp70 is shown here functioning as a sensor for protein triage decisions. In (A) hsp70 binds to the native state of the GR with a closed cleft to initiate GR-hsp90 heterocomplex assembly by forming a primed GR-hsp70 complex. In (B) hsp70 binds to a GR in the early stages of unfolding, and CHIP is bound, which, in turn, recruits ubiquitin-charged E2, leading to ubiquitylation and, ultimately, degradation by proteasome. As discussed in the text, these pathways are not exclusive; both hsp70 and CHIP are recovered in some native GR-hsp90 heterocomplexes. action to other hsp90 client proteins, it is possible to envision how hsp70 may function as the sensor for these protein triage decisions.
Conclusion
We have seen here how hsp90 is important for regulating proper folding, trafficking, nuclear cycling and turnover of the GR. The study of steroid receptor-hsp90 heterocomplexes has led to the discovery of the hsp90-/hsp70-based chaperone machinery and to the hsp90-binding immunophilins. The chaperone machinery is present in all eukaryotic cells. Even lysates from plants can form GR-hsp90 heterocomplexes with high-affinity steroid-binding activity that bind plant TPR domain immunophilins that, in turn, bind cytoplasmic dynein via their PPIase domains [33] . The hsp90 and hsp70 components of the machinery are functionally conserved, in that the plant chaperones can replace their homologues when mixed with purified animal chaperone proteins, with full activity being retained. When nucleated cells evolved, the genes for hsp90 and hsp70 duplicated and hsp90 became an essential protein, like hsp70 [2] . It was probably at this time that hsp90 and hsp70 began to work together as a machinery performing fundamental cellular functions through their ability to interact with native proteins by recognizing regions where hydrophobic clefts merge with the protein surface. It is not, therefore, surprising that new client proteins are identified each month, and it is likely that most signal transduction pathways will be regulated in some way by the chaperone machinery. • Formation of heterocomplexes with hsp90 prevents the ubiquitin ligase CHIP from promoting polyubiquitylation and receptor degradation via the proteasome.
Summary

